e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Lung infections: a clinical point of view
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhalations of the heated helium-oxygen mixture (heliox) as addition to standard therapy of community-acquired pneumonia
A. Krasnovskiy, S. Grigoriev, I. Zolkina, H. Loshkareva, A. Alehin, V. Potapov (Moscow, Russian Federation)
Source:
Annual Congress 2013 –Lung infections: a clinical point of view
Session:
Lung infections: a clinical point of view
Session type:
Thematic Poster Session
Number:
2203
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Krasnovskiy, S. Grigoriev, I. Zolkina, H. Loshkareva, A. Alehin, V. Potapov (Moscow, Russian Federation). Inhalations of the heated helium-oxygen mixture (heliox) as addition to standard therapy of community-acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2203
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Number of exacerbations in COPD patients treated with nasal high flow heated and humidified oxygen
Source: International Congress 2014 – COPD markers
Year: 2014
Continuous positive airway pressure (CPAP) treatment and mortality in community-acquired pneumonia (CAP)
Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation
Year: 2007
Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Aerosol vs. nebulisation: comparison of two methods of salbutamol administration in AECB hypercapnic respiratory failure requiring NIMV
Source: Annual Congress 2005 - Non-invasive ventilation: what's new?
Year: 2005
Lung deposition of two bronchodilators in subjects with (COPD) when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI).
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Effectiveness of nebulizing heliox coupled to bronchodilators and body positioning in severe asthma patients
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009
Heated heliox inhalations in treatment and rehabilitation of patients with with COPD
Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy
Year: 2009
Spirometry and multiple breath nitrogen washout (MBNW) before and after cold dry air challenge (CACh) in children and adolescents with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
High-flow nasal cannula heated-humidified (HFNC) oxygen (O2) at 2 litres (lt)/kg/min versus low-flow O2 (up to 2lt/min) in pediatric emergency department (PED) and pediatric ward (PW) in infants with bronchiolitis who need O2 administration: A combined prospective randomized controlled and retrospective study: Preliminary results
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
Use of heated humidified high flow nasal cannula therapy in a tertiary children’s hospital
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016
Surfactant-enforced treatment of
pseudomonas
-induced pneumonia
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Use of heated heliox-driven nebulizer therapy in the treatment of patients with bronchial asthma
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Study of adherence to the use of inhaled sodium colistimethate through the I-neb® nebulization system
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Fiberoptic bronchoscopy (FB) during noninvasive ventilation (NIV) in COPD with hypercapnic encephalopathy (he) and bronchial hypersecretion due to community-acquired pneumonia (CAP): a case-control study
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009
Children rhinosinusitis nebulizer inhalation therapy
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
Nebulized 3% hypertonic saline in the treatment of acute bronchiolitis in infants
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Baseline profiles of subjects randomised in RESPIRE 2 trial of ciprofloxacin dry powder for inhalation (DPI) in non-CF bronchiectasis (NCFB) by pathogen and prior exacerbation rate
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
COPD and pneumonia
Source: International Congress 2015 – Different data in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept